Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionClarius Group, LLC
Latest Disclosed Ownership983 shares
Latest Disclosed Value $ 445,653
Clarius Group, LLC reports 0.41% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On January 14, 2026 - Clarius Group, LLC filed a 13F-HR form disclosing ownership of 983 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $445,653 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 14, 2025 disclosing 987 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -0.41% during the quarter. The current value of the position is $421,058 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-14 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 983 -4 -0.41 446 15.28 0.0254
2025-10-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 987 -638 -39.26 387 -46.61 0.0229
2025-07-22 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,625 -193 -10.62 723 -17.93 0.0422
2025-04-18 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,818 440 31.93 881 59.03 0.0554
2025-01-16 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,378 -130 -8.62 555 -20.74 0.0379
2024-10-09 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,508 -48 -3.08 700 -4.12 0.0491
2024-07-11 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,556 -94 -5.70 729 5.81 0.0517
2024-04-17 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,650 -308 -15.73 690 -13.44 0.0476
2024-01-29 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,958 -127 -6.09 797 9.79 0.0661
2023-10-19 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,085 -415 -16.60 725 -17.52 0.0691
2023-08-10 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,500 48 1.96 880 13.86 0.0680
2023-04-17 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,452 -110 -4.29 773 0.0656
2023-01-25 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,562 62 2.48 1 -100.00 0.0666
2022-10-24 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,500 64 2.63 724 5.54 0.0724
2022-08-10 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,436 316 14.91 686 47.21 0.0685
2022-04-08 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,120 0 0.00 466 0.00 0.0369
2022-02-02 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,120 -76 -3.46 466 17.09 0.0369
2021-10-18 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,196 85 4.03 398 -6.57 0.0357
2021-08-06 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,111 -23 -1.08 426 -7.19 0.0382
2021-04-27 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,134 320 17.64 459 6.99 0.0450
2021-01-15 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,814 132 7.85 429 -6.33 0.0462
2020-10-09 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,682 -27 -1.58 458 -7.66 0.0588
2020-07-08 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,709 155 9.97 496 34.05 0.0695
2020-04-24 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,554 103 7.10 370 8.82 0.0698
2020-01-22 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,451 43 3.05 340 42.26 0.0538
2019-10-22 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,408 1,408 239 0.0438
2019-08-02 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,152 -100.00 0 -100.00
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,152 1,152 212 0.0516
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.